These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

479 related items for PubMed ID: 21162644

  • 1. The ACCEPT study: ustekinumab versus etanercept in moderate-to-severe psoriasis patients.
    Young MS, Horn EJ, Cather JC.
    Expert Rev Clin Immunol; 2011 Jan; 7(1):9-13. PubMed ID: 21162644
    [Abstract] [Full Text] [Related]

  • 2. Comparing biological therapies in psoriasis: implications for clinical practice.
    Griffiths CE.
    J Eur Acad Dermatol Venereol; 2010 Oct; 24 Suppl 6():10-4. PubMed ID: 20831704
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis.
    Uhlenhake EE, Feldman SR.
    Expert Opin Biol Ther; 2010 Jul; 10(7):1105-12. PubMed ID: 20446825
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. New biologic therapies for psoriatic disease.
    Bohjanen KA, Prawer SE.
    Minn Med; 2004 Mar; 87(3):34-6. PubMed ID: 15080292
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis.
    Martin S, Feldman SR, Augustin M, Szapary P, Schenkel B.
    J Dermatolog Treat; 2011 Jun; 22(3):138-43. PubMed ID: 21254886
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Effective and sustainable biologic treatment of psoriasis: what can we learn from new clinical data?
    Langley RG.
    J Eur Acad Dermatol Venereol; 2012 Mar; 26 Suppl 2():21-9. PubMed ID: 22356632
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Biological therapy and nail psoriasis.
    Lawry M.
    Dermatol Ther; 2007 Mar; 20(1):60-7. PubMed ID: 17403261
    [Abstract] [Full Text] [Related]

  • 19. An open-label, prospective cohort pilot study to evaluate the efficacy and safety of etanercept in the treatment of moderate to severe plaque psoriasis in patients who have not had an adequate response to adalimumab.
    Vender R.
    J Drugs Dermatol; 2011 Apr; 10(4):396-402. PubMed ID: 21455550
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.